Information

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Confirm

Key Opinions in Medicine

  • Register
  • Login
Skip to content
  • Issues
    • Allergy & Immunology
    • Cardiology
    • Conference
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes & Endocrinology
    • Gastroenterology
    • General Medicine
    • Haematology
    • Hepatology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Nursing
    • Obstetrics & Gynaecology
    • Oncology
    • Paediatrics
    • Psychiatry
    • Rheumatology
    • Surgery Insights
    • Urology
  • Register
  • Login

download

EADV 2020

EADV 2020

29. Kongress der European Academy of Dermatology and Venereology EADVIRTUAL 29.–31. Oktober 2020 Berichterstattung von großen medizinischen Kongressen Autorin: Dr. Susanne Kammerer...

IL-17A-Inhibitor Secukinumab jetzt auch bei Acne inversa zugelassen

IL-17A-Inhibitor Secukinumab jetzt auch bei Acne inversa zugelassen

Seit Kurzem ist der Interleukin (IL)-17A-Inhibitor Secukinumab zur Behandlung der Hidradenitis suppurativa (HS), auch bekannt als Acne inversa (AI), zugelassen1. Grundlage für die...

Second-line Treatment for Chronic Primary immune thrombocytopenia

Second-line Treatment for Chronic Primary immune thrombocytopenia

Primary immune thrombocytopenia (ITP) is a well-recognized autoimmune bleeding disorder characterized by isolated thrombocytopenia.1–3 Defective production or increased destruction of platelets4...

Why atopic dermatitis and prurigo nodularis are distinct diseases (US)

Why atopic dermatitis and prurigo nodularis are distinct diseases (US)

Highlights from a symposium sponsored by Sanofi and Regeneron Pharmaceuticals held during the 2023 American Academy of Dermatology annual meeting Mark Greener...

Adjuvant abemaciclib in HR+/HER2– high-risk early breast cancer: How are long-term monarchE data impacting clinical practice in South East Asia?

Adjuvant abemaciclib in HR+/HER2– high-risk early breast cancer: How are long-term monarchE data impacting clinical practice in South East Asia?

Up to 30% of patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2–) high-risk early breast cancer (EBC) will experience distant disease recurrence,...

Highlights of 2023 ASCO Genitourinary Cancers Symposium - Bladder and Urothelial Carcinoma

Highlights of 2023 ASCO Genitourinary Cancers Symposium

 

Bladder and Urothelial Carcinoma

Expert discussion With Dr Niara Oliveira, Mater Hospital Brisbane And Dr David Pook, Monash Cancer Centre...

The importance of antiviral therapy as a foundational treatment for patients hospitalized with COVID-19

The importance of antiviral therapy as a foundational treatment for patients hospitalized with COVID-19

In the early days of the COVID-19 pandemic, researchers, drug developers and healthcare providers raced against the clock to find solutions to slow the spread of SARS-CoV-2 and successfully treat the...

An Evolving World for Adults with Spinal Muscular Atrophy in Australia

An Evolving World for Adults with Spinal Muscular Atrophy in Australia

Spinal muscular atrophy (SMA) is a rare hereditary neuromuscular disease characterised by progressive deterioration in motor neuron function leading to increasing skeletal muscle weakness and...

An update in the management of X-linked hypophosphataemia

An update in the management of X-linked hypophosphataemia

  Key Points Impaired proximal renal tubular phosphate reabsorption due to the under-expression of sodium-phosphate cotransporters is the fundamental physiologic defect in XLH. Loss of function of...

Pegaspargase paediatric-inspired regimens for acute lymphoblastic leukaemia: An Australian perspective

Pegaspargase paediatric-inspired regimens for acute lymphoblastic leukaemia: An Australian perspective

Adult patients with acute lymphoblastic leukaemia (ALL) have a poorer prognosis in terms of cure rate, compared to the paediatric ALL population.1, 2 While adults achieve relatively high initial...

1 … 3 4 5 6 7 … 38

Search Issues

RSS Feeds

  • All issues

Popular Issues

Konkurrenz für den Therapiestandard

MOVICOL® (PEG3350 plus electrolytes): 20 years of evidence-based use

Copyright © 2000-2025 by John Wiley & Sons, Inc., or related companies. All rights reserved.
Review our privacy policy. Cookie Preferences.
Web design and marketing agency Leamington Spa